Our top pick for
Best for beginner
Cronos Australia is a pharmaceuticals business based in Australia. Cronos Australia shares (CAU) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Cronos Australia has a trailing 12-month revenue of around $67 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Cronos Australia
To buy shares listed in Australia such as Cronos Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
-
Open and fund your brokerage account. Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
-
Search for Cronos Australia. Find the share by name or ticker symbol: CAU. Research its history to confirm it's a solid investment against your financial goals.
-
Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos Australia reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
-
Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
-
Check on your investment. Congratulations, you own a part of Cronos Australia. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Education & learning
Finder Award
Our top pick for
Australian stocks
Finder Award
Cronos Australia stock price (ASX:CAU)
Use our graph to track the performance of CAU stocks over time.Cronos Australia shares at a glance
Information last updated 2023-07-13.
| 52-week range | $0 - $0 |
|---|---|
| 50-day moving average | $0.5683 |
| 200-day moving average | $0.498 |
| Target price | $1 |
| PE ratio | 54 |
| Dividend yield | $0.01 (1.85%) |
| Earnings per share (TTM) | $0.01 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 6 of 31
Is it a good time to buy Cronos Australia stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cronos Australia price performance over time
Historical closes compared with the last close of A$0.36
| 2 years (2022-04-22) | 16.13% |
|---|---|
| 3 years (2021-04-23) | 242.86% |
Is Cronos Australia under- or over-valued?
Valuing Cronos Australia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos Australia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cronos Australia's P/E ratio
Cronos Australia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Cronos Australia shares trade at around 54x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Cronos Australia's EBITDA
Cronos Australia's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.1 million (£0.0 million).
The EBITDA is a measure of a Cronos Australia's overall financial performance and is widely used to measure stock profitability.
Cronos Australia financials
| Revenue TTM | $67 million |
|---|---|
| Operating margin TTM | 14.81% |
| Gross profit TTM | $25.4 million |
| Return on assets TTM | 24% |
| Return on equity TTM | 40.03% |
| Profit margin | 8.98% |
| Book value | 0.047 |
| Market capitalisation | $300.5 million |
TTM: trailing 12 months
Cronos Australia share dividends
Dividend payout ratio: 100% of net profits
Recently Cronos Australia has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.85% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cronos Australia shareholders could enjoy a 1.85% return on their shares, in the form of dividend payments. In Cronos Australia's case, that would currently equate to about A$0.01 per share.
Cronos Australia's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 15 September 2022 (the "ex-dividend date").
Cronos Australia share price volatility
Over the last 12 months, Cronos Australia's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Cronos Australia's is 0.0683. This would suggest that Cronos Australia's shares are less volatile than average (for this exchange).
Cronos Australia overview
Cronos Australia Limited engages in the sale and distribution of medicinal cannabis products, and operation of medicinal cannabis clinic businesses in Australia and Asia. It operates through three segments: Medical, Clinics, and Consumer. The company sells its medicinal cannabis products under the Adaya brand, as well as through online marketplace platform. It also offers hemp seed oil personal care consumer products under the Bathing Shed brand; and CBD-based products under the FCTR and Saiph brands. The company was incorporated in 2018 and is based in South Yarra, Australia.
Stocks similar to Cronos Australia
ANZ Group Holdings Ltd. Pfd.
AUD101.63
-AUD0 (0.00%)
ANZ Group Holdings Ltd. Pfd.
AUD103.35
+AUD0.31 (0.32%)
Challenger Ltd Preferred
AUD106.46
+AUD0.44 (0.47%)
Macquarie Bank Ltd Pref
AUD106.27
+AUD0.16 (0.17%)
Macquarie Group Ltd Pref C
AUD102.80
-AUD0.24 (-0.25%)
Macquarie Group Preferred
AUD102.66
-AUD0.33 (-0.34%)
Suncorp Group Ltd Pref
AUD100.61
-AUD0.10 (-0.10%)
Westpac Banking Corp Pref
AUD102.76
-AUD0.28 (-0.29%)
Cronos Australia in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to invest in the Sun Silver IPO
Everything we know about the Sun Silver IPO, plus information on how to buy in.
-
How to invest in the Tasmea Limited IPO
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
-
How to buy Far Northern Resources shares
Steps to owning and managing Far Northern Resources shares.
-
What are the best commodity ETFs on the ASX in 2024?
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
-
Best performing stocks on the ASX in 2024 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
-
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
-
Superhero review: ASX and US share trading app
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
-
The cheapest ETFs on the ASX
These ETFs have the lowest fees on the market, but does that make them the best?
-
Alternatives to CommSec: 7 trading platforms to consider
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?
-
Westpac Share Trading Account review
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.
Ask a Question